Vascular effects of egg white-derived peptides in resistance arteries from rats. Structure-activity relationships

Journal of the Science of Food and Agriculture

Volumn 90, Issue 12, 2010, Pages 1988-1993

  Garcia Redondo, Ana B ^a   Roque, Fernanda R ^a   Miguel, Marta ^a,b   López Fandiño, Rosina ^b   Salaices, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO DE FERMENTACIONES INDUSTRIALES CSIC   (Spain)

Author keywords

ACE inhibitory activity; Antihypertensive activity; Bioactive peptides; Egg white proteins; Vasodilator properties

Indexed keywords

CAPTOPRIL; EGG PROTEIN; ENZYME INHIBITOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE; VASODILATOR AGENT;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; MALE; MESENTERIC ARTERY; METABOLISM; RAT; STRUCTURE ACTIVITY RELATION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; CAPTOPRIL; EGG PROTEINS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INDOMETHACIN; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDES; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR RESISTANCE; VASODILATOR AGENTS;

RATTUS;

EID: 77955929884     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.4037     Document Type: Article

References (43)

1. Nakamura Y, Yamamoto N, Sakai KY and Takano T, Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I converting enzyme. J Dairy Sci 78:1253-1257 (1995).
2. FitzGerald RJ, Murray BA and Walsh GJ, Hypotensive peptides from milk proteins. J Nutr 134:980S-988S (2004).
3. Muguerza B, Ramos M, Sánchez E, Manso MA, Miguel M, Aleixandre A, et al, Antihypertensive activity of milks fermented by Enterococcus faecalis strains isolated from raw milk. Int Dairy J 16:61-69 (2006).
4. Miguel M, Muguerza B, Sánchez E, Delgado MA, Recio I, Ramos M, et al, Changes in arterial blood pressure of milk fermented by Enterococcus faecalis CECT 5728 in spontaneously hypertensive rats. Br J Nutr 93:1-9 (2005).
5. Xu JY, Qin LQ, Wang PY, Li W and Chang C, Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 24:933-940 (2008).
6. Boelsma E and Kloek J, Lactotripeptides and antihypertensive effects: a critical review. Br J Nutr 101:776-786 (2009).
7. Usinger L, Ibsen H and Jensen LT, Does fermented milk possess antihypertensive effect in humans? J Hypertens 27:1115-1120 (2009).
8. Geleijnse JM and Engberink MF, Lactopeptides and human blood pressure. Curr Opin Lipidol 21:58-63 (2010).
9. Masuda O, Nakamura Y and Takano T, Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126:3063-3068 (1996).
10. Fuglsang A, Rattray FP, Nilsson D and Nyborg NC, Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie van Leeuwenhoek 83:27-34 (2003).
11. Fujita H and Yoshikawa M, LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44:123-127 (1999).
12. Fujita H, Saganuma H, Usui H, Kurahashi K, Nakagiri R, Sasaki R, et al, Vasorelaxation by casomokinin L, a derivative of B-casomorphin and casoxin D, is mediated by NK1 receptor. Peptides 17:635-639 (1996).
13. Sipola M, Finckenberg P, Vapaatalo H, Pihlanto-Leppälä A, Korhonen H, Korpela R, et al, α-Lactorphin and β-lactorphin improve arterial function in spontaneously hypertensive rats. Life Sci 71:1245-1253 (2002).
14. Kuono K, Hirano S, Kuboki H, Kasai M and Hatae K, Effects of dried bonito (Katsuobushi) and captopril, an angiotensin I-converting enzyme inhibitor, on rat isolated aorta: a possible mechanism of antihypertensive action. Biosci Biotechnol Biochem 69:911-915 (2005).
15. Dávalos A, Miguel M, Bartolomé B and López-Fandiño R, Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. J Food Protect 67:1939-1944 (2004).
16. Miguel M, Álvarez Y, López-Fandiño R, Alonso MJ and Salaices M, Vasodilator effects of peptides derived from egg white proteins. Regul Pept 140:131-135 (2007).
17. Hirota T, Ohki K, Kawagishi R, Kajimoto Y, Mizuno S, Nakamura Y, et al, Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res 30:489-496 (2007).
18. Ballard KD, Bruno RS, Seip RL, Quann EE, Volk BM, Freidenreich DJ, et al, Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial. Nutr J 8:34-45 (2009).
19. Miguel M, Recio I, Gómez-Ruiz JA, Ramos M and López-Fandiño R, Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis. J Food Protect 67:1914-1920 (2004).
20. Miguel M, López-Fandiño R, Ramos M and Aleixandre MA, Short-term effect of egg white hydrolysate products on the arterial blood pressure of hypertensive rats. Br J Nutr 94:731-737 (2005).
21. Miguel M, Aleixandre MA, Ramos M and López-Fandiño R, Effect of simulated gastrointestinal digestion on the antihypertensive properties of ACE-inhibitory peptides derived from ovalbumin. J Agric Food Chem 54:726-731 (2006).
22. Miguel M, López-Fandiño R, Ramos M and Aleixandre MA, Long-term intake of egg white hydrolysate attenuates the development of hypertension in spontaneously hypertensive rats. Life Sci 78:2960-2966 (2006).
23. Miguel M, Manso M, Aleixandre MA, Alonso MJ, Salaices M and López-Fandiño R, Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from eggwhite. JAgric FoodChem 55:10615-10621 (2007).
24. Mulvany MJ, The Fourth Sir George Pickerin Memorial Lecture. The structure of the resistance vasculature in essential hypertension. J Hypertens 5:129-136 (1987).
25. Intengan HD, Thibault G, Li JS and Schiffrin EL, Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 100:2267-2275 (1999).
26. Higashi Y, Sasaki S, Nakagawa K, Ueda T, Yoshimizu A, Kurisu S, et al, A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J AmColl Cardiol 35:284-291 (2000).
27. Vanhoutte PM, Shimokawa H, Tang EH and Feletou M, Endothelial dysfunction and vascular disease. Acta Physiol 196:193-222 (2009).
28. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S and Takano T, Purification and characterization of angiotensin-Iconverting enzyme inhibitors from a sour milk. J Dairy Sci 78:777-783 (1995).
29. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H and Nurminen ML, Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol 52:745-754 (2001).
30. Atherton E and Sheppard RC, Solid Phase Synthesis. A Practical Approach. IRL Press, Oxford, pp. 131-160 (1989).
31. Mulvany MJ and Halpern W, Contractile properties of small arterial resistance vessels in spontaneouslyhypertensive andnormotensive rats. Circ Res 41:19-26 (1977).
32. Osol G, Cipolla M and Knutson S, A new method for mechanically denuding the endothelium of small (50-150 microns) arteries with a human hair. Blood Vessels 26:320-324 (1989).
33. Matoba N, Usui H, Fujita H and Yoshikawa M, A novel antihypertensive peptide derived from ovalbumin induces nitric oxidemediated vasorelaxation in an isolated SHRmesenteric artery. FEBS Lett 452:181-184 (1999).
34. Hata Y, Yamamoto M, Ohni M, Nakajim K, Nakamura Y and Takano T, A placebo-controlled study of theeffectof sourmilkonbloodpressure in hypertensive subjects. Am J Clin Nutr 64:767-771 (1996).
35. Seppo L, Jauhiainen T, Poussa T and Korpela R, A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77:326-330 (2003).
36. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M and Korpela R, Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. AmJ Hypertens 18:1600-1605 (2005).
37. Scruggs P, Filipeanu CM, Yang J, Chang JK and Dun NJ, Interaction of ovokinin (2-7) with vascular bradykinin 2 receptors. Regul Pept 120:85-91 (2004).
38. Yamada Y, Yamauchi D, Yokoo M, Ohinata K, Usui H and Yoshikawa M, A potent hypotensive peptide, novokinin, induces relaxation by AT2- and IP-receptor-dependent mechanism in the mesenteric artery from SHRs. Biosci Biotechnol Biochem 72:257-259 (2008).
39. Fujita H, Usui H, Kurahashi K and Yoshikawa M, Isolation and characterization of ovokinin, a bradykinin B1 agonist peptide derived from ovalbumin. Peptides 16:785-790 (1995).
40. Fujita H, Sasaki R and Yoshikawa M, Potentiation of the antihypertensive activity of orally administered ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidylcholine. Biosci Biotech Biochem 12:2344-2345 (1995).
41. Mullaly MM, Meisel H and FitzGerald RJ, Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem Hoppe Seyler 377:259-260 (1996).
42. Yamamoto N, Maeno M and Takano T, Purification and characterization of an antihypertensive peptide from a yogurtlike product fermented by Lactobacillus helveticus CPN4. JDairy Sci 82:1388-1393 (1999).
43. Suetsuna K, Isolation and characterization of angiotensin I-converting enzyme inhibitor dipeptides derived from allium sativum L (garlic). J Nutr Biochem 9:415-419 (1998).